Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Minoxidil effectively treats female pattern hair loss.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Oral zinc sulphate reduces dark hair color in mice.